Iridex to Participate in Fireside Chat with Stifel Equity Research

Rhea-AI Summary

Iridex Corporation (NASDAQ: IRIX), a leader in ophthalmic laser-based medical products, announced its participation in a fireside chat with Stifel's equity research analyst. This discussion is scheduled for December 8, 2022, at 9:00 a.m. PT / 12:00 p.m. ET. The event will be accessible via a live and archived webcast on the Company’s website. Iridex specializes in innovative laser systems for treating glaucoma and retinal diseases, using its proprietary MicroPulse® technology. The Company's products are distributed both in the U.S. and over 100 countries worldwide.

MOUNTAIN VIEW, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in a fireside chat with its covering equity research analyst from Stifel.

Management is scheduled to discuss the business on Thursday, December 8, 2022 at 9:00 a.m. PT / 12:00 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.

About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse^® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Investor Relations Contact:
Philip Taylor
(415) 937-5406
investors@iridex.com

FAQ

What is the date and time of Iridex's fireside chat?

Iridex's fireside chat is scheduled for December 8, 2022, at 9:00 a.m. PT / 12:00 p.m. ET.

Who will participate in the Iridex fireside chat?

The fireside chat will feature Iridex's management and its covering equity research analyst from Stifel.

Where can I watch the Iridex fireside chat?

The fireside chat can be viewed live and archived on the Investors section of the Iridex website.

What technology does Iridex use for its ophthalmic products?

Iridex utilizes its proprietary MicroPulse® technology for its laser-based medical products.

In which markets does Iridex operate?

Iridex's products are sold in the United States, Germany, and over 100 countries through independent distributors.